144 related articles for article (PubMed ID: 20608938)
1. Relationship between cyclooxygenase-2 and human epidermal growth factor receptor 2 in vascular endothelial growth factor C up-regulation and lymphangiogenesis in human breast cancer.
Bhattacharjee RN; Timoshenko AV; Cai J; Lala PK
Cancer Sci; 2010 Sep; 101(9):2026-32. PubMed ID: 20608938
[TBL] [Abstract][Full Text] [Related]
2. [Study of the correlation between HER-2 gene and lymphangiogenesis and their prognostic significance in human breast cancer].
Zhang GH; Yang WT; Zhou XY; Zeng Y; Lu HF; Shi DR
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):155-60. PubMed ID: 17425844
[TBL] [Abstract][Full Text] [Related]
3. COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer.
Timoshenko AV; Chakraborty C; Wagner GF; Lala PK
Br J Cancer; 2006 Apr; 94(8):1154-63. PubMed ID: 16570043
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel mechanism of lymphangiogenesis in lung adenocarcinoma.
Su JL; Shih JY; Yen ML; Jeng YM; Chang CC; Hsieh CY; Wei LH; Yang PC; Kuo ML
Cancer Res; 2004 Jan; 64(2):554-64. PubMed ID: 14744769
[TBL] [Abstract][Full Text] [Related]
5. Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer.
Zhang XH; Huang DP; Guo GL; Chen GR; Zhang HX; Wan L; Chen SY
BMC Cancer; 2008 Jan; 8():4. PubMed ID: 18190720
[TBL] [Abstract][Full Text] [Related]
6. [The effect of cyclooxygenase-2 on lymphangiogenesis in breast cancer].
Guo GL; Yang GL; Li ZY; You J; Yang K; Huang DP; Hu XQ; Zhang XH
Zhonghua Wai Ke Za Zhi; 2008 Jan; 46(2):132-5. PubMed ID: 18509974
[TBL] [Abstract][Full Text] [Related]
7. Expression and clinical significance of extracellular matrix protein 1 and vascular endothelial growth factor-C in lymphatic metastasis of human breast cancer.
Wu QW; She HQ; Liang J; Huang YF; Yang QM; Yang QL; Zhang ZM
BMC Cancer; 2012 Jan; 12():47. PubMed ID: 22284579
[TBL] [Abstract][Full Text] [Related]
8. Expressions of COX-2 and VEGF-C in gastric cancer: correlations with lymphangiogenesis and prognostic implications.
Gou HF; Chen XC; Zhu J; Jiang M; Yang Y; Cao D; Hou M
J Exp Clin Cancer Res; 2011 Jan; 30(1):14. PubMed ID: 21272377
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological significance of lymphangiogenesis and tumor lymphovascular invasion in indonesian breast cancers.
Widodo I; Ferronika P; Harijadi A; Triningsih FE; Utoro T; Soeripto
Asian Pac J Cancer Prev; 2013; 14(2):997-1001. PubMed ID: 23621275
[TBL] [Abstract][Full Text] [Related]
10. Peritumoral lymphangiogenesis induced by vascular endothelial growth factor C and D promotes lymph node metastasis in breast cancer patients.
Zhao YC; Ni XJ; Li Y; Dai M; Yuan ZX; Zhu YY; Luo CY
World J Surg Oncol; 2012 Aug; 10():165. PubMed ID: 22906075
[TBL] [Abstract][Full Text] [Related]
11. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.
Guo B; Zhang Y; Luo G; Li L; Zhang J
Anat Rec (Hoboken); 2009 May; 292(5):633-9. PubMed ID: 19382240
[TBL] [Abstract][Full Text] [Related]
12. HER2/neu expression correlates with vascular endothelial growth factor-C and lymphangiogenesis in lymph node-positive breast cancer.
Schoppmann SF; Tamandl D; Roberts L; Jomrich G; Schoppmann A; Zwrtek R; Dubsky P; Gnant M; Jakesz R; Birner P
Ann Oncol; 2010 May; 21(5):955-60. PubMed ID: 19940005
[TBL] [Abstract][Full Text] [Related]
13. RNA interference (RNAi)-mediated vascular endothelial growth factor-C (VEGF-C) reduction interferes with lymphangiogenesis and enhances epirubicin sensitivity of breast cancer cells.
Sun P; Gao J; Liu YL; Wei LW; Wu LP; Liu ZY
Mol Cell Biochem; 2008 Jan; 308(1-2):161-8. PubMed ID: 17938864
[TBL] [Abstract][Full Text] [Related]
14. COX-2 expression is correlated with VEGF-C, lymphangiogenesis and lymph node metastasis in human cervical cancer.
Liu H; Xiao J; Yang Y; Liu Y; Ma R; Li Y; Deng F; Zhang Y
Microvasc Res; 2011 Sep; 82(2):131-40. PubMed ID: 21600223
[TBL] [Abstract][Full Text] [Related]
15. Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression.
Choi WW; Lewis MM; Lawson D; Yin-Goen Q; Birdsong GG; Cotsonis GA; Cohen C; Young AN
Mod Pathol; 2005 Jan; 18(1):143-52. PubMed ID: 15297858
[TBL] [Abstract][Full Text] [Related]
16. [Lymphangiogenes and location of tumor lymphatic vessels induced by VEGF-C in primary breast carcer].
Huang JH; Li Y; Liu L; Yang HC; Hai J; Tang LL; Hu TH
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 31(1):36-9, 51. PubMed ID: 16562672
[TBL] [Abstract][Full Text] [Related]
17. [Role of matrix metalloproteinase (MMP)-2 and -9 and vascular endothelial growth factor C in lymph node metastasis of breast cancer].
Zheng SQ; Huang RQ; Zhang YJ
Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):240-4. PubMed ID: 20654122
[TBL] [Abstract][Full Text] [Related]
18. Both high expression of pyruvate kinase M2 and vascular endothelial growth factor-C predicts poorer prognosis in human breast cancer.
Lin Y; Liu F; Fan Y; Qian X; Lang R; Gu F; Gu J; Fu L
Int J Clin Exp Pathol; 2015; 8(7):8028-37. PubMed ID: 26339369
[TBL] [Abstract][Full Text] [Related]
19. Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model.
Xin X; Majumder M; Girish GV; Mohindra V; Maruyama T; Lala PK
Lab Invest; 2012 Aug; 92(8):1115-28. PubMed ID: 22641101
[TBL] [Abstract][Full Text] [Related]
20. Tumor-derived VEGF-C, but not VEGF-D, promotes sentinel lymph node lymphangiogenesis prior to metastasis in breast cancer patients.
Zhao YC; Ni XJ; Wang MH; Zha XM; Zhao Y; Wang S
Med Oncol; 2012 Dec; 29(4):2594-600. PubMed ID: 22562155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
